Efficacy of Bifidobacterium breve CECT7263 for infantile colic treatment: an open-label, parallel, randomised, controlled trial
Open Access
- 24 February 2021
- journal article
- research article
- Published by Brill in Beneficial Microbes
- Vol. 12 (1), 55-68
- https://doi.org/10.3920/bm2020.0105
Abstract
Infantile colic is a prevalent condition characterised by excessive crying with no effective treatment available. We aimed to evaluate the efficacy of Bifidobacterium breve CECT7263 and a combinati...This publication has 47 references indexed in Scilit:
- Recent advances in understanding and managing infantile colicF1000Research, 2018
- Lactobacillus reuteri for Infants with Colic: A Double-Blind, Placebo-Controlled, Randomized Clinical TrialThe Journal of Pediatrics, 2017
- Childhood Functional Gastrointestinal Disorders: Neonate/ToddlerGastroenterology, 2016
- Effect of Infant Formula Containing a Low Dose of the Probiotic Bifidobacterium lactis CNCM I-3446 on Immune and Gut Functions in C-Section Delivered Babies: A Pilot StudyClinical Medicine Insights: Pediatrics, 2016
- Characterizing the Intestinal Microbiome in Infantile ColicBiological Research For Nursing, 2015
- Probiotics for Infantile Colic: A Randomized, Double-Blind, Placebo-Controlled Trial Investigating Lactobacillus reuteri DSM 17938The Journal of Pediatrics, 2014
- Management of infantile colicBMJ, 2013
- Intestinal Microbiota of Infants With Colic: Development and Specific SignaturesPEDIATRICS, 2013
- Lactobacillus fermentum CECT 5716 is safe and well tolerated in infants of 1–6 months of age: A Randomized Controlled TrialPharmacological Research, 2012
- Is colic a gastrointestinal disorder?Current Opinion in Pediatrics, 2002